Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-10-02 4:45 pm Purchase | 2023-09-29 | 13G | Morphic Holding, Inc. MORF | Point72 Asset Management, L.P. | 2,504,383 5.200% | 2,504,383![]() (New Position) | Filing History |
2023-09-29 4:33 pm Purchase | 2023-09-28 | 13G | Bionomics Limited BNOX | Point72 Asset Management, L.P. | 9,924,390 8.100% | 9,924,390![]() (New Position) | Filing History |
2023-09-18 4:24 pm Purchase | 2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 3,727,952 5.600% | 3,727,952![]() (New Position) | Filing History |
2023-09-15 5:11 pm Purchase | 2023-09-14 | 13G | Cybin Inc. CYBN | Point72 Asset Management, L.P. | 498,684 8.100% | 498,684![]() (New Position) | Filing History |
2023-07-27 4:20 pm Purchase | 2023-07-25 | 13G | Turnstone Biologics Corp. TSBX | Point72 Asset Management, L.P. | 1,383,314 6.200% | 1,383,314![]() (New Position) | Filing History |
2023-07-27 4:15 pm Purchase | 2023-07-26 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 2,824,930 5.000% | 904,677![]() (+47.11%) | Filing History |
2023-07-20 4:54 pm Purchase | 2023-07-19 | 13G | Chewy, Inc. CHWY | Point72 Asset Management, L.P. | 6,705,883 5.800% | 6,705,883![]() (New Position) | Filing History |
2023-07-20 4:15 pm Purchase | 2023-07-18 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 4,085,544 5.100% | 4,085,544![]() (New Position) | Filing History |
2023-06-26 4:30 pm Purchase | 2023-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 761,834 8.900% | 687,889![]() (+930.26%) | Filing History |
2023-06-01 5:00 pm Purchase | 2023-05-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 3,562,902 5.000% | 3,562,902![]() (New Position) | Filing History |
2023-05-24 5:15 pm Purchase | 2023-05-17 | 13G | Elevation Oncology, Inc. ELEV | Point72 Asset Management, L.P. | 2,121,170 8.700% | 2,121,170![]() (New Position) | Filing History |
2023-05-16 4:02 pm Purchase | 2023-05-15 | 13G | CUTERA INC CUTRQ | Point72 Asset Management, L.P. | 1,144,407 5.800% | 1,144,407![]() (New Position) | Filing History |
2023-04-05 4:23 pm Purchase | 2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 4,533,756 5.000% | 2,095,618![]() (+85.95%) | Filing History |
2023-03-09 4:17 pm Purchase | 2022-12-31 | 13G | Cepton, Inc. CPTN | Point72 Asset Management, L.P. | 181,523 1.200% | 181,523![]() (New Position) | Filing History |
2023-02-23 7:43 pm Purchase | 2023-02-22 | 13G | Inari Medical, Inc. NARI | Point72 Asset Management, L.P. | 2,795,352 5.200% | 2,795,352![]() (New Position) | Filing History |
2023-02-17 4:35 pm Purchase | 2023-02-16 | 13G | Iovance Biotherapeutics, Inc. IOVA | Point72 Asset Management, L.P. | 8,114,890 5.000% | 8,114,890![]() (New Position) | Filing History |
2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management, L.P. | 3,114,107 6.700% | 1,131,546![]() (+57.07%) | Filing History |
2023-02-14 4:25 pm Purchase | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management, L.P. | 3,515,356 7.100% | 116,695![]() (+3.43%) | Filing History |
2023-02-14 4:23 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 7,702,831 9.200% | 1,094,273![]() (+16.56%) | Filing History |
2023-02-14 4:23 pm Sale | 2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 193,400 5.400% | -22,502![]() (-10.42%) | Filing History |